Submitted by J.M. Arasteh on Fri, 08/05/2020 - 20:43
Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology.
Read original news article here>